Daiichi Sankyo (OTCMKTS:DSNKY) Releases Quarterly Earnings Results

Daiichi Sankyo (OTCMKTS:DSNKYGet Free Report) announced its quarterly earnings results on Friday. The company reported $0.22 EPS for the quarter, Zacks reports. Daiichi Sankyo updated its FY 2024 guidance to 0.840-0.840 EPS.

Daiichi Sankyo Stock Performance

OTCMKTS:DSNKY traded up $0.55 during mid-day trading on Friday, hitting $28.66. 246,773 shares of the stock were exchanged, compared to its average volume of 192,069. The firm’s 50-day simple moving average is $28.50 and its 200 day simple moving average is $33.03. Daiichi Sankyo has a fifty-two week low of $25.11 and a fifty-two week high of $42.48.

About Daiichi Sankyo

(Get Free Report)

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.

Featured Stories

Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daiichi Sankyo and related companies with MarketBeat.com's FREE daily email newsletter.